CSIMarket Company Name, Ticker, Competitors, else..
 

Zogenix Inc   (NASDAQ: ZGNX)

Zogenix Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

ZGNX Sales vs. its Competitors Q4 2021


Comparing the current results to its competitors, Zogenix Inc reported Revenue increase in the 4 quarter 2021 by 212.95 % year on year.
The sales growth was above Zogenix Inc 's competitors' average revenue growth of 67.5 %, achieved in the same quarter.

• List of ZGNX Competitors

With a net margin of 233.09 % Zogenix Inc achieved higher profitability than its competitors.

• More on ZGNX Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison

Zogenix Inc achieved net profit of $62.02 millions compared to a net loss of $-70.17 millions recorded in the same quarter a year ago.

<<  ZGNX Stock Performance Comparisons





  

Overall company Market Share Q4 2021
Due to outstanding performance in Overall company, revenue grew by 212.95 % Zogenix Inc improved its market share, to approximately 22.3 %.




<<  More on ZGNX Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Zogenix Inc




Agile Therapeutics Inc
Share Performance



+4.86%
30 Days
Agile Therapeutics Inc
Profile

is a women's healthcare

More about Agile Therapeutics Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 10.353 mill. $ 19.722 mill. $ -15.854 mill.


Harmony Biosciences Holdings inc
Share Performance



+51.27%
One Year
Harmony Biosciences Holdings inc
Profile

Harmony Biosciences Holdings Inc's business model revolves around the development and commercialization of innovative therapies for patients with sleep disorders.

More about Harmony Biosciences Holdings inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2,378.417 mill. $ 960.191 mill. $ 181.270 mill.


Ovid Therapeutics Inc
Share Performance



+83.57%
One Year
Ovid Therapeutics Inc
Profile

Ovid Therapeutics Inc's business model is focused on developing and commercializing innovative medicines for the treatment of rare neurological disorders.

More about Ovid Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 1.583 mill. $ -34.492 mill.

Sources: Zogenix Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Zogenix Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.